T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Arthur J. Gallagher & Co
AJG
$65B
| $40.1M | 0.01% |
491,420
+32,635
| +7% | +$3.13M |
|
|
CHX
852
DELISTED
ChampionX
CHX
| $39.8M | 0.01% |
6,919,619
+3,775,481
| +120% | +$78.5M |
|
853
Brown-Forman Class B
BF.B
$12.9B
| $39.8M | 0.01% |
716,085
+7,671
| +1% | +$493K |
|
854
Brady Corp
BRC
$4.43B
| $39.5M | 0.01% |
874,487
-142,440
| -14% | -$7.25M |
|
855
ScottsMiracle-Gro
SMG
$3.59B
| $39.4M | 0.01% |
385,054
+14,805
| +4% | +$1.63M |
|
856
Texas Roadhouse
TXRH
$13.6B
| $39.2M | 0.01% |
948,122
-56,601
| -6% | -$3.13M |
|
857
Gold Fields
GFI
$35.4B
| $39.1M | 0.01% |
8,230,795
-1,255,727
| -13% | -$7.67M |
|
858
Virtus Investment Partners
VRTS
$1.14B
| $39.1M | 0.01% |
513,262
+86,614
| +20% | +$9.77M |
|
859
Valero Energy
VLO
$98.7B
| $39.1M | 0.01% |
861,075
-345,250
| -29% | -$25.1M |
|
860
Ovintiv
OVV
$17.2B
| $39M | 0.01% |
14,437,180
+7,457,464
| +107% | +$97.9M |
|
861
Bausch Health
BHC
$2.37B
| $39M | 0.01% |
+2,514,611
| New | +$60.6M |
|
862
OSI Systems
OSIS
$3.77B
| $38.9M | 0.01% |
564,965
+9,596
| +2% | +$820K |
|
863
Grocery Outlet
GO
$1.07B
| $38.9M | 0.01% |
1,133,103
-874,857
| -44% | -$28.5M |
|
|
PPL
864
PPL Corp
PPL
$26.8B
| $38.8M | 0.01% |
1,571,602
+212,408
| +16% | +$6.84M |
|
865
NewMarket
NEU
$8.72B
| $38.7M | 0.01% |
101,132
+163
| +0.2% | +$68.8K |
|
866
Lantheus
LNTH
$6.59B
| $38.7M | 0.01% |
3,029,621
-154,184
| -5% | -$2.46M |
|
867
Krystal Biotech
KRYS
$9.72B
| $38.6M | 0.01% |
892,824
-157,761
| -15% | -$8.25M |
|
868
Q32 Bio
QTTB
$458M
| $38.5M | 0.01% |
137,769
-16,644
| -11% | -$5.1M |
|
|
TWTR
869
DELISTED
Twitter, Inc.
TWTR
| $38.5M | 0.01% |
1,567,448
+134,646
| +9% | +$4.36M |
|
870
Hexcel
HXL
$7.74B
| $38.3M | 0.01% |
1,029,809
+36,278
| +4% | +$2.34M |
|
871
Cinemark Holdings
CNK
$4.37B
| $38.2M | 0.01% |
3,746,328
+3,705,749
| +9,132% | +$95.1M |
|
872
Murphy Oil
MUR
$4.99B
| $38M | 0.01% |
6,192,356
-1,509,540
| -20% | -$27.8M |
|
|
GTLS
873
DELISTED
Chart Industries
GTLS
| $37.8M | 0.01% |
1,304,864
-581,958
| -31% | -$31.6M |
|
874
AMC Global Media
AMCX
$496M
| $37.7M | 0.01% |
1,551,464
+770,749
| +99% | +$26.1M |
|
|
CFB
875
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $37.7M | 0.01% |
4,488,795
+511,494
| +13% | +$6.17M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.